ARCHIVES

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center

July 25, 2013

DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year

May 12, 1978

In Brief: DOE honors radiation Therapy Pioneers; Center Honors Nixon, Lansing, Coffey

June 20, 1997

CHOP Evaluation Plan In Jan. 22 Issue

January 15, 1982

Groups Urge Passage of Health Care Reform Legislation

January 29, 2010